Cargando…
COVID-19 and cognitive impairment: neuroinvasive and blood‒brain barrier dysfunction
Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has led to a global pandemic. Although COVID-19 was initially described as a respiratory disease, there is growing evidence that SARS-CoV-2 is able to invade the brains of COVID-19 patients a...
Autores principales: | Chen, Yanting, Yang, Wenren, Chen, Feng, Cui, Lili |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9450840/ https://www.ncbi.nlm.nih.gov/pubmed/36071466 http://dx.doi.org/10.1186/s12974-022-02579-8 |
Ejemplares similares
-
Immune response and blood–brain barrier dysfunction during viral neuroinvasion
por: Chen, Zhuangzhuang, et al.
Publicado: (2020) -
Mechanisms of restriction of viral neuroinvasion at the blood–brain barrier
por: Miner, Jonathan J, et al.
Publicado: (2016) -
Progressive cognitive impairment after recovery from neuroinvasive and non-neuroinvasive Listeria monocytogenes infection
por: Cassidy, Benjamin R., et al.
Publicado: (2023) -
Blood–Brain Barrier Dysfunction and the Potential Mechanisms in Chronic Cerebral Hypoperfusion Induced Cognitive Impairment
por: Xu, WenQing, et al.
Publicado: (2022) -
The TAM receptor Mertk protects against neuroinvasive viral infection by maintaining blood-brain barrier integrity
por: Miner, Jonathan J., et al.
Publicado: (2015)